Subscribe To
KROS / Keros Therapeutics: Undercovered Company With Data From All Programs
Content Topics
Keros
Therapeutics
Undercovered
Company
With
Data
From
Therapeutics
Programs
Stock
KROS
KROS News
By Zacks Investment Research
May 1, 2023
Keros Therapeutics, Inc. (KROS) Upgraded to Buy: Here's What You Should Know
Keros Therapeutics, Inc. (KROS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This m more_horizontal
By Seeking Alpha
April 30, 2023
Keros Therapeutics: Undercovered Company With Data From All Programs
KROS is a small company with three clinical programs. Surprisingly, each program has clinical data. more_horizontal
By The Motley Fool
April 21, 2023
Why Shares of Keros Therapeutics Jumped This Week
Keros is a pre-revenue biotech with two therapies in phase 2 trials. The company focuses on treatments for blood and musculoskeletal disorders. more_horizontal
By Zacks Investment Research
March 2, 2023
Is a Surprise Coming for Keros Therapeutics (KROS) This Earnings Season?
Keros Therapeutics (KROS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal
By Seeking Alpha
February 10, 2023
Keros Therapeutics: Market Rewarding KER-050 Trial Momentum
Data is promising for KROS' KER-050 compound; investors are rewarding the company on its novel hypotheses. We performed a deep dive on its most recent more_horizontal
By Zacks Investment Research
December 23, 2022
Keros Therapeutics, Inc. (KROS) Upgraded to Buy: Here's What You Should Know
Keros Therapeutics, Inc. (KROS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank more_horizontal
By Zacks Investment Research
November 8, 2022
Keros Therapeutics, Inc. (KROS) Upgraded to Buy: Here's What You Should Know
Keros Therapeutics, Inc. (KROS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This m more_horizontal